OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
83 hedge funds and large institutions have $107M invested in OncoMed Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
57% less capital invested
Capital invested by funds: $247M → $107M (-$140M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
83
Holding in Top 10
1
Calls
$2.25M
Puts
$1.05M
Top Buyers
| 1 | +$3.52M | |
| 2 | +$1.86M | |
| 3 | +$1.68M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.67M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$1.13M |
Top Sellers
| 1 | -$5.37M | |
| 2 | -$3.96M | |
| 3 | -$3.89M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.67M |
| 5 |
Morgan Stanley
New York
|
-$1.31M |